| AACR Project GENIE: powering precision medicine through an international consortium AACR Project Genie Consortium, AACR Project GENIE Consortium, ... Cancer discovery 7 (8), 818-831, 2017 | 1715 | 2017 |
| Tumour heterogeneity in the clinic PL Bedard, AR Hansen, MJ Ratain, LL Siu Nature 501 (7467), 355-364, 2013 | 1467 | 2013 |
| Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies M Hidalgo, LL Siu, J Nemunaitis, J Rizzo, LA Hammond, C Takimoto, ... Journal of clinical oncology 19 (13), 3267-3279, 2001 | 1286 | 2001 |
| Dose escalation methods in phase I cancer clinical trials C Le Tourneau, JJ Lee, LL Siu JNCI: Journal of the National Cancer Institute 101 (10), 708-720, 2009 | 1098 | 2009 |
| Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of … D Soulieres, NN Senzer, EE Vokes, M Hidalgo, SS Agarwala, LL Siu Journal of clinical oncology 22 (1), 77-85, 2004 | 1035 | 2004 |
| Tumour-and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review L Khoja, D Day, TWW Chen, LL Siu, AR Hansen Annals of Oncology 28 (10), 2377-2385, 2017 | 1010 | 2017 |
| Molecular profiling for precision cancer therapies ER Malone, M Oliva, PJB Sabatini, TL Stockley, LL Siu Genome medicine 12 (1), 8, 2020 | 960 | 2020 |
| Toward understanding and exploiting tumor heterogeneity AA Alizadeh, V Aranda, A Bardelli, C Blanpain, C Bock, C Borowski, ... Nature medicine 21 (8), 846-853, 2015 | 914 | 2015 |
| The statins as anticancer agents KKW Chan, AM Oza, LL Siu Clinical cancer research 9 (1), 10-19, 2003 | 785 | 2003 |
| Deintensification candidate subgroups in human papillomavirus–related oropharyngeal cancer according to minimal risk of distant metastasis B O'Sullivan, SH Huang, LL Siu, J Waldron, H Zhao, B Perez-Ordonez, ... Journal of clinical oncology 31 (5), 543-550, 2013 | 714 | 2013 |
| Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials CA Townsley, R Selby, LL Siu Journal of clinical oncology 23 (13), 3112-3124, 2005 | 707 | 2005 |
| Small molecules, big impact: 20 years of targeted therapy in oncology PL Bedard, DM Hyman, MS Davids, LL Siu The Lancet 395 (10229), 1078-1088, 2020 | 677 | 2020 |
| Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong … AWM Lee, WH Lau, SY Tung, DTT Chua, R Chappell, L Xu, L Siu, ... Journal of Clinical Oncology 23 (28), 6966-6975, 2005 | 642 | 2005 |
| Circulating tumor DNA and liquid biopsy in oncology DW Cescon, SV Bratman, SM Chan, LL Siu Nature cancer 1 (3), 276-290, 2020 | 588 | 2020 |
| Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus–related oropharyngeal carcinomas SH Huang, W Xu, J Waldron, L Siu, X Shen, L Tong, J Ringash, A Bayley, ... Journal of clinical oncology 33 (8), 836-845, 2015 | 481 | 2015 |
| Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab SV Bratman, SYC Yang, MAJ Iafolla, Z Liu, AR Hansen, PL Bedard, ... Nature cancer 1 (9), 873-881, 2020 | 480 | 2020 |
| Beyond immune checkpoint blockade: emerging immunological strategies SP Kubli, T Berger, DV Araujo, LL Siu, TW Mak Nature reviews Drug discovery 20 (12), 899-919, 2021 | 443 | 2021 |
| Randomized trial of radiotherapy plus concurrent–adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma AWM Lee, SY Tung, DTT Chua, RKC Ngan, R Chappell, R Tung, L Siu, ... Journal of the National Cancer Institute 102 (15), 1188-1198, 2010 | 431 | 2010 |
| Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial JJ Knox, D Hedley, A Oza, R Feld, LL Siu, E Chen, M Nematollahi, ... Journal of Clinical Oncology 23 (10), 2332-2338, 2005 | 400 | 2005 |
| A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas I Duran, J Kortmansky, D Singh, H Hirte, W Kocha, G Goss, L Le, A Oza, ... British journal of cancer 95 (9), 1148-1154, 2006 | 392 | 2006 |
